430 related articles for article (PubMed ID: 34295334)
21. The NOTCH-HES-1 axis is involved in promoting Th22 cell differentiation.
Zeng C; Shao Z; Wei Z; Yao J; Wang W; Yin L; YangOu H; Xiong D
Cell Mol Biol Lett; 2021 Feb; 26(1):7. PubMed ID: 33622250
[TBL] [Abstract][Full Text] [Related]
22. IL-21 and autoimmune disease--hypothesis and reality?
Holmdahl R
Eur J Immunol; 2008 Jul; 38(7):1800-2. PubMed ID: 18546147
[TBL] [Abstract][Full Text] [Related]
23. Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer.
Liu T; Peng L; Yu P; Zhao Y; Shi Y; Mao X; Chen W; Cheng P; Wang T; Chen N; Zhang J; Liu X; Li N; Guo G; Tong W; Zhuang Y; Zou Q
J Clin Immunol; 2012 Dec; 32(6):1332-9. PubMed ID: 22760549
[TBL] [Abstract][Full Text] [Related]
24. Intra-tumoral IFN-γ-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer.
Niccolai E; Taddei A; Ricci F; Rolla S; D'Elios MM; Benagiano M; Bechi P; Bencini L; Ringressi MN; Pini A; Castiglione F; Giordano D; Satolli MA; Coratti A; Cianchi F; Bani D; Prisco D; Novelli F; Amedei A
Clin Sci (Lond); 2016 Feb; 130(4):247-58. PubMed ID: 26590104
[TBL] [Abstract][Full Text] [Related]
25. Th22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome.
Shao LL; Zhang L; Hou Y; Yu S; Liu XG; Huang XY; Sun YX; Tian T; He N; Ma DX; Peng J; Hou M
PLoS One; 2012; 7(12):e51339. PubMed ID: 23236476
[TBL] [Abstract][Full Text] [Related]
26. Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease.
Truchetet ME; Brembilla NC; Montanari E; Allanore Y; Chizzolini C
Arthritis Res Ther; 2011; 13(5):R166. PubMed ID: 21996293
[TBL] [Abstract][Full Text] [Related]
27. Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials.
Deng Y; Wang Z; Chang C; Lu L; Lau CS; Lu Q
Hum Immunol; 2017 Feb; 78(2):120-128. PubMed ID: 28040536
[TBL] [Abstract][Full Text] [Related]
28. Emerging role of IL-35 in inflammatory autoimmune diseases.
Su LC; Liu XY; Huang AF; Xu WD
Autoimmun Rev; 2018 Jul; 17(7):665-673. PubMed ID: 29729445
[TBL] [Abstract][Full Text] [Related]
29. Biological effects of IL-21 on different immune cells and its role in autoimmune diseases.
Gharibi T; Majidi J; Kazemi T; Dehghanzadeh R; Motallebnezhad M; Babaloo Z
Immunobiology; 2016 Feb; 221(2):357-67. PubMed ID: 26466984
[TBL] [Abstract][Full Text] [Related]
30. Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets.
Czarnowicki T; Esaki H; Gonzalez J; Malajian D; Shemer A; Noda S; Talasila S; Berry A; Gray J; Becker L; Estrada Y; Xu H; Zheng X; Suárez-Fariñas M; Krueger JG; Paller AS; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Oct; 136(4):941-951.e3. PubMed ID: 26242300
[TBL] [Abstract][Full Text] [Related]
31. Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus.
Lin J; Yue LH; Chen WQ
Scand J Immunol; 2014 Feb; 79(2):131-6. PubMed ID: 24313261
[TBL] [Abstract][Full Text] [Related]
32. Follicular helper T cell in immunity and autoimmunity.
Mesquita D; Cruvinel WM; Resende LS; Mesquita FV; Silva NP; Câmara NO; Andrade LE
Braz J Med Biol Res; 2016; 49(5):e5209. PubMed ID: 27096200
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 27: a double-edged sword for offense and defense.
Yoshida H; Nakaya M; Miyazaki Y
J Leukoc Biol; 2009 Dec; 86(6):1295-303. PubMed ID: 19801497
[TBL] [Abstract][Full Text] [Related]
34. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited.
Boniface K; Blom B; Liu YJ; de Waal Malefyt R
Immunol Rev; 2008 Dec; 226():132-46. PubMed ID: 19161421
[TBL] [Abstract][Full Text] [Related]
35. Th17 cells: a new fate for differentiating helper T cells.
Chen Z; O'Shea JJ
Immunol Res; 2008; 41(2):87-102. PubMed ID: 18172584
[TBL] [Abstract][Full Text] [Related]
36. Effects of high-dose dexamethasone on regulating interleukin-22 production and correcting Th1 and Th22 polarization in immune thrombocytopenia.
Cao J; Chen C; Li L; Ling-yu Z; Zhen-yu L; Zhi-ling Y; Wei C; Hai C; Sang W; Kai-lin X
J Clin Immunol; 2012 Jun; 32(3):523-9. PubMed ID: 22289995
[TBL] [Abstract][Full Text] [Related]
37. Th22 and related cytokines in inflammatory and autoimmune diseases.
Tian T; Yu S; Ma D
Expert Opin Ther Targets; 2013 Feb; 17(2):113-25. PubMed ID: 23256771
[TBL] [Abstract][Full Text] [Related]
38. Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis.
Zhang L; Li JM; Liu XG; Ma DX; Hu NW; Li YG; Li W; Hu Y; Yu S; Qu X; Yang MX; Feng AL; Wang GH
J Clin Immunol; 2011 Aug; 31(4):606-14. PubMed ID: 21556937
[TBL] [Abstract][Full Text] [Related]
39. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease.
Aktas Cetin E; Cosan F; Cefle A; Deniz G
Mod Rheumatol; 2014 Sep; 24(5):802-7. PubMed ID: 24498963
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of the Th1, Th17, and Th22 pathways due to anti-TNF-α treatment in psoriasis.
Luan L; Han S; Wang H; Liu X
Int Immunopharmacol; 2015 Dec; 29(2):278-284. PubMed ID: 26585971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
